论文部分内容阅读
作者对膀胱移行细胞癌行膀胱切除并用回肠袢尿流转向的180例病人进行了回顾性研究。男148例,女32例。年龄34～77岁。除了采用体检定期随访和血生化检查估价肾机能外,所有病人在术后3个月和1年后作IVU,此后间隔3年作一次。如有临床指征时再随时作IVU并且用US、肠袢造影和顺行性造影进一步研究。对全组病人确定上尿路肿瘤的发病率,特别强调这些肿瘤如何存在及常规造影的价值。结果表明,除了16例在术后3个月内死亡外,所有病人术后至少作1次IVU。在术后1～9年发生上尿路肿瘤10例,均不是常规IVU随诊时检出。其中9例因主诉血尿后IVU检出,而在6个
The authors performed a retrospective study of 180 patients with bladder transitional cell carcinoma undergoing cystectomy and diverting ileocecal urinary flow. There were 148 males and 32 females. Age 34 to 77 years old. In addition to the periodic physical examination and blood biochemical tests to assess the function of the kidney, all patients after 3 months and 1 year after the IVU, after an interval of 3 years once. IVU is available anytime for clinical indications and is further studied with US, bowel angiography and congenital angiography. The incidence of upper urinary tract tumors was determined for all patients, with particular emphasis on the existence of these tumors and the value of conventional radiography. The results showed that, except for 16 patients died within 3 months after surgery, all patients at least once for IVU. In the 1 to 9 years after the occurrence of upper urinary tract tumors in 10 cases, are not routine IVU detected. Among them, 9 cases were detected by IVU after hematuria and 6 cases